2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$9.61+$0.06 (+0.59%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.6BMarket Cap
- 263.12%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$9.61+$0.06 (+0.59%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.55 | ||
Change | +$0.27 (+2.91%) | ||
Open | $9.56 | ||
High | $9.90 | ||
Low | $9.50 | ||
Previous Close | $9.28 | ||
Volume | 2,332,934 | ||
30-Day Average Volume | 2,632,182 | ||
1-Week Change | 4.03% | ||
1-Month Change | 14.78% | ||
1-Year Change | 263.12% | ||
3-Year Change | 471.86% | ||
5-Year Change | -57.59% | ||
Fundamentals | |||
Shares Outstanding | 171.6M | ||
Total Assets | $268.9M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $318,000.00 | ||
Net Income | -$33.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$33.2M | ||
EBITDA | -$30.5M | ||
Net Working Capital | $188.7M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | 4,815 | ||
P/B | 7 | ||
P/E | -45 | ||
PEG | 4 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue